The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2024
Filed:
Mar. 19, 2021
Applicants:
Trustees of Boston University, Boston, MA (US);
Massachusetts Institute of Technology, Cambridge, MA (US);
Inventors:
Arturo Vegas, Belmont, MA (US);
Sean Quinnell, Brookline, MA (US);
Daniel Sheehy, Roslindale, MA (US);
Kelly Tan, Boston, MA (US);
Luke Ceo, Boston, MA (US);
Stephen Thomas Nestor, Boston, MA (US);
Angela Nicole Koehler, Wellesley, MA (US);
Becky Leifer, Malden, MA (US);
Shelby Doyle, Cambridge, MA (US);
Assignees:
Trustees of Boston University, Boston, MA (US);
Massachusetts Institute of Technology, Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/14 (2006.01); A61K 45/06 (2006.01); C07D 207/09 (2006.01); C07D 211/96 (2006.01); C07D 213/85 (2006.01); C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 401/14 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 405/04 (2006.01); C07D 409/04 (2006.01); C07D 417/06 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); A61K 45/06 (2013.01); C07D 207/09 (2013.01); C07D 211/96 (2013.01); C07D 213/85 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 409/04 (2013.01); C07D 417/06 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01); C07K 16/2866 (2013.01);
Abstract
The technology described herein is directed to IL-4 and/or IL-13 inhibitors and uses thereof.